| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A common TBP-binding site mutation elevates fetal hemoglobin levels by competitive globin switching change in β-thalassemia
|
Song, Mengyang
|
|
|
9 |
13 |
p. 3159-3169
|
artikel
|
| 2 |
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes
|
Trněný, Marek
|
|
|
9 |
13 |
p. 3263-3267
|
artikel
|
| 3 |
Antibiotic use: impact on the microbiome and cellular therapy outcomes
|
Darwin, Alicia
|
|
|
9 |
13 |
p. 3356-3367
|
artikel
|
| 4 |
Autologous stem cell transplantation for relapsed/refractory large B-cell lymphoma: a multicenter GETH-TC/GELTAMO study
|
Bento, Leyre
|
|
|
9 |
13 |
p. 3281-3292
|
artikel
|
| 5 |
Bridging radiotherapy before chimeric antigen receptor T cells for B-cell lymphomas: an ILROG multicenter study
|
Yegya-Raman, Nikhil
|
|
|
9 |
13 |
p. 3293-3303
|
artikel
|
| 6 |
Canagliflozin may increase thromboembolic events in males with erythrocytosis but not in females
|
Doi, Yohei
|
|
|
9 |
13 |
p. 3202-3212
|
artikel
|
| 7 |
Can we harmonize classification of TP53 mutant MDS/AML?
|
Sallman, David A.
|
|
|
9 |
13 |
p. 3381-3382
|
artikel
|
| 8 |
Complement C5 inhibition in early onset HELLP syndrome
|
Gerber, Gloria F.
|
|
|
9 |
13 |
p. 3304-3307
|
artikel
|
| 9 |
COVID-19 and CLL in Sweden: lessons learned?
|
Mulligan, Stephen P.
|
|
|
9 |
13 |
p. 3223-3225
|
artikel
|
| 10 |
Critical bleeding in adults and children with immune thrombocytopenia: a multicenter cohort study
|
Sirotich, Emily
|
|
|
9 |
13 |
p. 3238-3248
|
artikel
|
| 11 |
Discrepancy between original and adapted ASH VTE guidelines: same clinical evidence but different recommendations
|
Rezende, Suely Meireles
|
|
|
9 |
13 |
p. 3182-3189
|
artikel
|
| 12 |
Early daratumumab therapy improves renal outcomes in newly diagnosed patients with myeloma admitted with kidney injury
|
Kim, E. Bridget
|
|
|
9 |
13 |
p. 3129-3135
|
artikel
|
| 13 |
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations
|
Shah, Mithun Vinod
|
|
|
9 |
13 |
p. 3370-3380
|
artikel
|
| 14 |
Expression and treatment of ROR1+ cells with bispecific T-cell engagers in pediatric acute lymphoblastic leukemia
|
Diamanti, Paraskevi
|
|
|
9 |
13 |
p. 3190-3201
|
artikel
|
| 15 |
Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups
|
Knabe, Ricarda
|
|
|
9 |
13 |
p. 3336-3339
|
artikel
|
| 16 |
Immunological consequences of CAR T-cell therapy: an analysis of infectious complications and immune reconstitution
|
Riedel, Andreas
|
|
|
9 |
13 |
p. 3149-3158
|
artikel
|
| 17 |
Impact of haplo-donor age on transplant outcomes: a comparative analysis of haploidentical vs cord blood transplantation
|
Nagayama, Takashi
|
|
|
9 |
13 |
p. 3226-3237
|
artikel
|
| 18 |
LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies
|
Li, Yang
|
|
|
9 |
13 |
p. 3310-3314
|
artikel
|
| 19 |
Loss of factor VIII in zebrafish rebalances antithrombin deficiency but has a limited bleeding diathesis
|
Raghunath, Azhwar
|
|
|
9 |
13 |
p. 3136-3148
|
artikel
|
| 20 |
Mature megakaryocytes acquire immune characteristics in a mouse model of aplastic anemia
|
Prabahran, Ashvind
|
|
|
9 |
13 |
p. 3315-3330
|
artikel
|
| 21 |
Multiplexed imaging mass cytometry elicits p-S6 as a therapeutic and prognostic factor in diffuse large B-cell lymphoma
|
Zhang, Bo
|
|
|
9 |
13 |
p. 3249-3262
|
artikel
|
| 22 |
Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022
|
Gopal, Ajay K.
|
|
|
9 |
13 |
p. 3383-3394
|
artikel
|
| 23 |
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704
|
Sorror, Mohamed L.
|
|
|
9 |
13 |
p. 3268-3280
|
artikel
|
| 24 |
Outcomes of the COVID-19 pandemic in chronic lymphocytic leukemia: focus on the very early period and Omicron era
|
Hedberg, Pontus
|
|
|
9 |
13 |
p. 3170-3181
|
artikel
|
| 25 |
Patients with AML and an IDH2-R172 mutation exhibit a unique initial response to intensive chemotherapy induction
|
Yisraeli Salman, Meira
|
|
|
9 |
13 |
p. 3213-3222
|
artikel
|
| 26 |
Restarting teclistamab and talquetamab after prolonged dose delay may not require re–step-up dosing
|
Tan, Carlyn Rose
|
|
|
9 |
13 |
p. 3331-3335
|
artikel
|
| 27 |
The differential expression of circulating microRNAs in sickle cell trait compared with the normal hemoglobin phenotype
|
Olaniran, Kabir
|
|
|
9 |
13 |
p. 3350-3355
|
artikel
|
| 28 |
Throwing the microbiome out with the bathwater
|
Geer, Marcus
|
|
|
9 |
13 |
p. 3368-3369
|
artikel
|
| 29 |
Validation of risk assessment models for venous thromboembolism in patients with cancer receiving systemic therapies
|
Vladić, Nikola
|
|
|
9 |
13 |
p. 3340-3349
|
artikel
|
| 30 |
Younger haplo-donors improve older patient survival outcomes
|
Ghorab, Ahmad
|
|
|
9 |
13 |
p. 3308-3309
|
artikel
|
Tijdschrift beschrijving